Industry Reporter: Massachusetts: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Industry Reporter: Massachusetts.

Press releases published on October 5, 2026

Proficient Auto Logistics Sets Date to Report Third Quarter 2026 Financial Results; Announces Participation in Stephens Annual Investment Conference
US Elemental Announces Commencement of McDermitt Phase 1 Drilling Program
O-I Glass Announces Third Quarter 2026 Earnings Conference Call and Webcast
Uniti Group Inc. To Report Third Quarter 2026 Financial Results and Host Conference Call
ONEOK Schedules Third-Quarter 2026 Conference Call and Webcast
Sound Community Bank Named One of American Banker’s 2026 Most Powerful Women Led Teams in Banking
Merlin, Inc. To Participate in Upcoming Investor Conferences
Government Business Results Expands Public Sector Go-to-Market Services with New Partner Marketing Practice
Arqitech signs agreement with ThinkEquity to build a multi-asset platform under the ThinkEquity brand
Korro Announces First Cohort Dosed in Phase 1/2 Clinical Trial (ANCHOR) for KRRO-121
NanoXplore Announces the Creation of an Advisory Board for Its Subsidiary VoltaXplore and Appoints Galvion Founder and Executive Chairman Jonathan Blanshay as Inaugural Member
NanoXplore annonce la création d’un Conseil consultatif pour sa filiale VoltaXplore et nomme Jonathan Blanshay, fondateur et président exécutif de Galvion, à titre de membre inaugural
Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED
Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504
Polar Power Rejects Solidion All-Cash Offer for Company Assets
Leonardo DRS Completes Training and Delivery of INOD Block III Thermal Weapon Sights for the Australian Army
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock
Big Bear Gold Corp. Announces Change of Transfer Agent to Olympia Trust Company
Environmental Toxins and Brain Health: Experts Explore Cognitive Decline, Alzheimer’s Research and Therapeutic Plasma Exchange
FDA Clears Motivista (CT-155), the First Authorized Treatment for Negative Schizophrenia Symptoms

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Industry Reporter: Massachusetts

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.